Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells

Inflammation Research

Volumn 48, Issue 2, 1999, Pages 86-93

  Gibbs, B F ^a   Schmutzler, W ^b   Vollrath, I B ^a   Brosthardt, P ^b   Braam, U ^b   Wolff, H H ^a   Zwadlo Klarwasser, G ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Ambroxol; Leukocyte; Mast cell; Mediator; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; AMBROXOL; COMPLEMENT COMPONENT C5A; COMPOUND 48-80; CONCANAVALIN A; CYTOKINE; EXPECTORANT AGENT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HISTAMINE; INTERLEUKIN 13; INTERLEUKIN 4; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; SUPEROXIDE; ZYMOSAN;

ADENOID; ARTICLE; BASOPHIL; CELL STIMULATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MAST CELL; MEDIATOR RELEASE; MONOCYTE; PATHOGENESIS; RADIOIMMUNOASSAY; RESPIRATORY TRACT DISEASE; SKIN; SPECTROFLUOROMETRY;

AMBROXOL; ANTI-INFLAMMATORY AGENTS; CYTOKINES; HISTAMINE RELEASE; HUMANS; LEUKOCYTES; LEUKOTRIENES; MAST CELLS;

EID: 0032983760     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050421     Document Type: Article

References (33)

1. Felix K, Pairet M, Zimmermann R. The antioxidative activity of the mucoregulatory agents: Ambroxol, bromhexine and N-acetyl-L-cysteine. A pulse radiolysis study. Life Sci 1996;59:1141-7.
2. Gillissen A, Scharling B, Jaworska M, Bartling A, Rasche K, Schultze-Werninghaus G. Oxidant scavenger function of ambroxol in vitro: a comparison with N-acetylcysteine AC. Res Exp Med (Berl) 1997;196:389-98.
3. Fantone JC, Ward PA. Role of oxygen-derived radicals and metabolites in leukocyte dependent inflammatory reactions. Am J Pathol 1982;107:395-418.
4. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 1991;91:14S-22.
5. Pairet M, Engelmann P, Von-Nicolai H, Champeroux P, Richard S, Rauber G, et al. Ambroxol improves the broncho-spasmolytic activity of clenbuterol in the guinea-pig. J Pharm Pharmacol 1997;49:184-6.
6. Pfeifer S, Zissel G, Kienast K, Muller-Quernhaim J. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol. Eur J Med Res 1997;2:129-32.
7. Walton NG, Mann TA, Shaw KM. Anaphylactoid reaction to N-acetylcysteine. Lancet 1979;2:1298.
8. Barrett KE, Minor JR, Metcalfe DD. Histamine secretion induced by N-acetyl cysteine. Agents Actions 1985;16:144-6.
9. Jeannin P, Delneste Y, Lecoanet-Henchoz S, Gauchet JF, Life P, Holmes D, et al. Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis. J Exp Med 1995;182:1785-92.
10. Wolfreys K, Oliveira DB. Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur J Immunol 1997;27:297-306.
11. Benyon RC, Lowman MA, Church MK. Human skin mast cells: Their dispersion, purification and secretory characterization. J Immunol 1987;138:861-7.
12. Massay WA, Lichtenstein LM. Role of basophils in human allergic disease. Int Arch Allergy Immunol 1992;99:184-8.
13. Maruyama N, Tamura G, Aizawa T, Ohrui T, Shimura S, Shirato K, et al. Accumulation of basophils and their chemotactic activity in the airways during natural airway narrowing in asthmatic individuals. Am J Crit Care Med 1994;150:1086-93.
14. Gibbs BF, Haas H, Falcone FH, Albrecht C, Vollrath IB, Noll T, et al. Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation. Eur J Immunol 1996;26:2493-8.
15. Li H, Sim CS, Alam R. IL-13 released by and localized in human basophils. J Immunol 1996;156:4833-8.
16. Ochensberger B, Daepp G-C, Rihs S, Dahinden CA. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation. Blood 1996;88:3028-37.
17. Del Prete G. Human Th1 and Th2 lymphocytes: Their role in the pathophysiology of atopy. Allergy 1992;47:450-5.
18. Masinovsky B, Urdal D, Gallatin WM. IL-4 acts synergistically with IL-1β to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J Immunol 1990;145:2886-95.
19. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995;154:799-803.
20. Wallengren J, Hakanson R. Effects of capsiacin, bradykinin and prostaglandin E2 in the human skin. Br J Dermatol 1992;126:111-7.
21. Bach MK, Brashler JR, Petzold EN, Sanders ME. Superoxide production by human eosinophils can be inhibited in an agonist-selective manner. Agents Actions 1992;35:1-11.
22. Zwadlo-Klarwasser G, Servais MD, Schmutzler W, Brosthardt P, Braam U. Ambroxol inhibits histamine release from human adenoidal mast cells. Inflamm Res 1998;47 Suppl 1:S/6-7.
23. Schmutzler W, Delmich K, Eichelberg D, Glück S, Greven T, Jürgensen H, et al. The human adenoidal mast cell. Susceptibility to different secretagogues and secretion inhibitors. Int Arch Allergy Appl Immunol 1985;77:177-8.
24. Gibbs BF, Noll T, Falcone FH, Haas H, Vollmer E, Vollrath I, et al. A three-step procedure for the purification of human basophils from buffy coat blood. Inflamm Res 1997;46:137-42.
25. MacGlashan D, White JM, Huang S-K, Ono SJ, Schroeder JT, Lichtenstein LM. Secretion of IL-4 from human basophils. J Immunol 1994;152:3006-16.
26. Redrup AC, Howard BP, MacGlashan DW, Kagey-Sobotka A, Lichtenstein LM, Schroeder JT. Differential regulation of IL-4 and IL-13 secretion by human basophils: their relationship to histamine release in mixed leukocyte cultures. J Immunol 1998;160:1957-64.
27. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. J Clin Lab Invest 1968;21:S77-9.
28. Zwadlo G, Bröcker EB, Von Bassewitz DB, Feige U, Sorg C. A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol 1985;134:1487-92.
29. Babior BM, Kipnes RS, Curnutt JT. Biological defense mechanisms - the production by leukocytes of superoxide, a potent bactericidal agent. J Clin Invest 1973;52:741-4.
30. Winsel K. Antioxidative und entzündungshemmende Eigenschaften von Ambroxol. Pneumologie 1992;46:461-75.
31. Heath MF, Jacobson W. The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant. Lung 1985;163:337-44.
32. Harvima RJ, Schwartz LB. Mast cell-derived mediators. In: Foreman J, editor. Immunopharmacology of mast cells and basophils. London: Academic Press, 1993:115-38.
33. Schroeder JT, MacGlashan DW. The basophil. J Allergy Clin Immunol 1997;99:429-33.